Bladder cancer Board decisions

The Board denied service connection for the cause of the Veteran's death and entitlement to burial benefits, as there was no evidence linking the Veteran's bladder cancer to his military service or any other service-connected condition.

The Board denied service connection for prostate cancer with urinary incontinence, chronic obstructive pulmonary disease (COPD), aortic insufficiency, and urothelial carcinoma (bladder cancer) as the evidence did not support a nexus between these conditions and the Veteran's military service.

The appeals for increased ratings and service connection were dismissed due to untimely filings.

The Board denied service connection for diabetes mellitus, type II, cardiovascular disability, hypertension, thyromegaly, prostate cancer, and bladder cancer as there is no evidence of in-service exposure to herbicide agents or that the disabilities are related to such exposure.

The Board granted service connection for bladder cancer based on the Veteran's exposure to tactical herbicides during active-duty service.

The Veteran withdrew his appeal for an increased evaluation for bladder cancer prior to May 1, 2021.

The Board denied service connection for obstructive sleep apnea, peripheral neuropathy of both upper and lower extremities, and bladder cancer as the evidence did not support a finding that these conditions were related to the Veteran's active military service or any service-connected disability.

The Board granted service connection for bladder cancer, finding that the Veteran's exposure to aqueous film forming foam (AFFF) during his military service caused the condition.

The Board denied service connection for a left ankle disorder, a left leg disorder, and an acquired psychiatric disorder, to include PTSD. However, it granted an initial rating of 20 percent for residuals of bladder cancer and 10 percent for a scar of the left lower quadrant.

The Board denied the Appellant's claim for accrued benefits based on a pending service connection claim for bladder and bone cancer, as no service-connected benefits were due or payable at the time of the Veteran's death.

The Board granted an earlier effective date of February 17, 2021 for the award of service connection for bladder cancer.

The Board remands the case to correct pre-decisional duty to assist errors related to the Veteran's claim for an earlier effective date for service connection of residuals of bladder cancer, specifically regarding herbicide exposure.

The Board granted service connection for the cause of the Veteran's death, finding that his metastatic bladder cancer was likely incurred in or caused by his active service due to exposure to toxic chemicals, including benzene.

The Board denied an earlier effective date for the award of a 20 percent rating and a higher disability rating for residuals of bladder cancer.

The Veteran's claims for earlier effective dates and increased ratings were partially granted, with some issues remanded.

The Board denied service connection for the cause of the Veteran's death, as there was no evidence that his COPD or bladder cancer were related to his military service.

The appeal for service connection for bladder cancer, progressive supra nuclear palsy, diabetes mellitus type II, and gastroesophageal reflux disease (GERD) was dismissed due to the Veteran's death during the pendency of the appeal.

The Board denied a compensable disability rating for the Veteran's residuals of bladder cancer, as the symptoms were attributed to non-service-connected benign prostatic hyperplasia.

The appeal was withdrawn by the appellant, and therefore, it is dismissed.

The Board granted earlier effective dates of August 27, 2021 for bladder cancer and September 23, 2021 for diabetes mellitus type II due to the Veteran's service in Thailand.